As part of a TANOVEA CA-1 Tuesdays webinar, Douglas H. Thamm, VMD, DACVIM
(Oncology), presents information for veterinarians on possible adverse effects of treatment with the
canine lymphoma drug, and explores strategies for anticipating and mitigating common
This month’s vlog is an excerpt from VetDC’s past webinar on anticipating and addressing adverse effects of TANOVEA-CA1, recorded in May 2017. To view the full webinar on this topic, please click here.
The segment is approximately five minutes in length.
For more information on TANOVEA-CA1 please go to tanovea.com.
Tanovea-CA1 webinar replays are intended for use by veterinary health care professionals only!